Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Clonal Hematopoiesis, MDS Biology

Benjamin Ebert

MD, PhD

🏢Dana-Farber Cancer Institute🌐USA

Chair, Medical Oncology

110
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Benjamin Ebert co-discovered clonal hematopoiesis of indeterminate potential as a common age-related condition associated with increased mortality. His laboratory further elucidated the mechanism of lenalidomide in del(5q) MDS through targeted protein degradation. He leads translational programs investigating clonal evolution in myeloid malignancies.

Share:

🧪Research Fields 研究领域

CHIP
MDS
lenalidomide mechanism
hematopoiesis
myeloid malignancy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Benjamin Ebert 的研究动态

Follow Benjamin Ebert's research updates

留下邮箱,当我们发布与 Benjamin Ebert(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment